The proposed study is a pilot randomized control trial to determine the efficacy of
dexamethasone use in hospitalized children who are less than 2 years of age with
non-respiratory syncytial virus (RSV) bronchiolitis admitted to the University of Pittsburgh
Medical Center (UPMC) Children's Hospital of Pittsburgh from February 1 to May 31, 2022. It
is hypothesized that the use of standard airway-dose steroids (0.6mg/kg dexamethasone) will
improve the clinical outcome of children hospitalized for non-RSV bronchiolitis, which will
be evident by decreased length of stay.